Invention Grant
- Patent Title: Combination therapies for heme malignancies with anti-CD38 antibodies and survivin inhibitors
-
Application No.: US15189577Application Date: 2016-06-22
-
Publication No.: US10668149B2Publication Date: 2020-06-02
- Inventor: Parul Doshi , Henk M. Lokhorst , Tuna Mutis
- Applicant: Janssen Biotech, Inc.
- Applicant Address: US PA Horsham
- Assignee: Janssen Biotech, Inc.
- Current Assignee: Janssen Biotech, Inc.
- Current Assignee Address: US PA Horsham
- Agency: Hamilton, Brook, Smith & Reynolds, P.C.
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K9/00 ; C07K16/28 ; A61K31/497 ; A61K38/47 ; A61K39/00
Abstract:
The present invention relates to combination therapies for heme malignancies with anti-CD38 antibodies and survivin inhibitors.
Public/Granted literature
- US20160367663A1 Combination therapies for heme malignancies with Anti-CD38 antibodies and survivin inhibitors Public/Granted day:2016-12-22
Information query
